Skip to Content


In the US, Digibind (digoxin immune fab systemic) is a member of the drug class antidotes and is used to treat Digitalis Glycoside Toxicity.

US matches:

Ingredient matches for Digibind

Digitalis Antitoxin

Digitalis Antitoxin is reported as an ingredient of Digibind in the following countries:

  • Australia

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.